CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Grant or award Vice President, Operations acquired 1,875 shares (grant or award)
- 4 Grant or award President and CEO acquired 18,750 shares (grant or award)
- 4 Grant or award VP Bus Dev & Con Mfg acquired 4,750 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Exercise or conversion VP Bus Dev & Con Mfg acquired 6,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 16,446 shares (option exercise)
- 4 Open-market sale Vice President, Operations sold 3,500 shares at $43.26 ($151,410)
- 4 Gift President and CEO gave 1,320 shares (gift)
- 4 Open-market buy President and CEO bought 2,500 shares at $40.95 ($102,375)
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Vice President and CFO acquired 19,060 shares (option exercise)
- 4 Exercise or conversion Vice President and CFO acquired 2,106 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
- 4 Exercise or conversion Vice President, Operations acquired 7,395 shares (option exercise)
- 4 Exercise or conversion VP Bus Dev & Con Mfg acquired 9,062 shares (option exercise)
- 4 Shares withheld for taxes VP and CFO gave up 653 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,469 shares (to pay taxes)
- 4 Exercise or conversion Vice President, Operations acquired 9,020 shares (option exercise)
Page 25 of 42 · 835 filings